healthcare

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

China is facing an outbreak of the coronavirus, which may have spread to a few other countries in East Asia. Although less than 300 infections have been reported, there are ...
Read Full Story »

Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference

For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week. In fact, brokerage firm Janney spent last week visiting ...
Read Full Story »

This Week’s Biggest Biotech Movers

As the biotechnology group is pushing near all-time highs, this past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these ...
Read Full Story »

Will Hexo’s Direct Offering Help Push the Stock Higher?

Hexo Corp. (NYSE: HEXO) shares slid on Friday after the Canadian cannabis firm announced that it is conducting a direct offering of $20 million worth of shares. The effort is ...
Read Full Story »

What’s Next for Durect After FDA Posimir Vote

Durect Corp. (NASDAQ: DRRX) shares dropped early on Friday after the U.S. Food and Drug Administration Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) announced its vote on Posimir, the ...
Read Full Story »

Are Neon Therapeutics’ Shareholders Getting Enough in the Buyout?

Neon Therapeutics Inc. (NASDAQ: NTGN) shares shot up on Thursday after the firm announced that it will be acquired by BioNTech SE (NASDAQ: BNTX). The question is: Are Neon Therapeutics ...
Read Full Story »

Can Tilray Stock Make a Comeback?

When Canadian cannabis grower Tilray Inc. (NASDAQ: TLRY) came public in the United States in July of 2018, the company's initial public offering priced at $17 a share, above the ...
Read Full Story »

Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock

Nektar Therapeutics (NASDAQ: NKTR) shares were crushed on Wednesday after the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management ...
Read Full Story »

Does FDA Decision Mean a Bright Future for This Flu Vaccine?

Novavax Inc. (NASDAQ: NVAX) shares jumped on Wednesday after the U.S. Food and Drug Administration (FDA) granted a Fast Track Designation for NanoFlu, its recombinant quadrivalent seasonal influenza vaccine candidate, ...
Read Full Story »

Organigram Stock High on Results and on Expected Products Coming in 2020

Organigram Holdings Inc. (NASDAQ: OGI) was one of the top stock market gainers on Wednesday after the cannabis and cannabis-derived products seller posted earnings. Many pot stocks have tried to ...
Read Full Story »

Does UnitedHealth Deserve More Credit for Q4?

When UnitedHealth Group Inc. (NYSE: UNH) reported its fourth-quarter financial results before the markets opened on Wednesday, the Minnesota-based health care giant said that it had $3.90 in earnings per ...
Read Full Story »

Growing Number of Americans Still Don’t Think Vaccines Are Important

There is an ongoing battle in the United States about whether vaccines are useful as a way to protect people, and in particular children, from a disease. A minority of ...
Read Full Story »

Will UnitedHealth Lift the Dow Again When It Reports Wednesday?

UnitedHealth Group Inc. (NYSE: UNH) is scheduled to report its most recent quarterly results before the opening bell on Wednesday. The consensus estimates call for $3.78 in earnings per share ...
Read Full Story »

Why Aquestive Therapeutics’ Seizure Treatment May Get Butted Out

Aquestive Therapeutics Inc. (NASDAQ: AQST) shares lost nearly a third on Monday after the firm received an update from the U.S. Food and Drug Administration (FDA). The long and short ...
Read Full Story »

This T-Cell Therapy Could Be a Game Changer for Adaptimmune

Adaptimmune Therapeutics PLC (NASDAQ: ADAP) shares absolutely exploded on Monday after the company announced encouraging responses for its Spear T-cell platform. These results were announced that the JPMorgan Healthcare Conference, ...
Read Full Story »